ECHA | Transparent progress in addressing substances of concern | Integrated Regulatory Strategy Annual Report - April 2021
ECHA’s Integrated Regulatory Strategy aims to accelerate data generation, identification of
groups of substances of concern, and regulatory action. It does so by providing a setup where
different regulatory processes can be coherently, effectively and efficiently used, and by
encouraging collaboration between ECHA, Member States and the European Commission.
The strategy’s goal is to clarify by 2027 which registered substances are a high priority for
regulatory risk management or data generation, and which are currently a low priority for further
The group approach – where structurally similar substances are addressed together rather than
substance by substance – supports these objectives by enhancing the efficiency of authorities’
work, helping them focus on substances of potential concern and to identify appropriate
regulatory actions. The mapping of the chemical universe increases the transparency of
The results of 2020 show that the strategy has accelerated regulatory action on substances of
concern and increased transparency, predictability and efficiency. In particular, by working on
groups of substances and pooling all available information together, we have been able to
substantially increase the number of substances being considered for regulatory risk
The most visible development is the progress made in clearing the ‘not yet assigned’ pool. The
number of substances registered above 100 tonnes per year that were not yet assigned
decreased by 26 % compared to August 2019 figures when the first universe mapping was done.
Similar trends are also visible for substances registered at lower tonnages.
Link to the Integrated Regulatory Strategy Annual Report - April 2021